Thought Leadership
End of a Patent Battle, Beginning of a Licensing Fight for CRISPR
March 7, 2022
Tulika Rastogi
IPWatchdog

Axinn partner David Silverstein was quoted in the IPWatchdog article, "End of a Patent Battle, Beginning of a Licensing Fight for CRISPR."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.